Vaccine Adjuvants Global Market Report 2025

Global Vaccine Adjuvants Market Report 2024

Vaccine Adjuvants Global Market Report 2025 – By Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types), By Route of Application (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), By Route of Administration (Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal), By Disease (Cancer, Infectious Diseases, Other Diseases) – Market Size, Trends, And Global Forecast 2025-2034

Name: Vaccine Adjuvants Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Vaccine Adjuvants Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Vaccine Adjuvants Global Market Report 2025

Proud Members Of

Vaccine Adjuvants Market Definition

Vaccine adjuvants are compounds or ingredients used in vaccines that enhance the body's immunogenic response to antigens that lack immunostimulatory capabilities and help to create a stronger immune response.

The main types of products of vaccine adjuvants are adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and others such as saponin-based adjuvants. An adjuvant emulsion is a mixture of two or more ordinarily immiscible liquids. The route of application includes human vaccine adjuvants and veterinary vaccine adjuvants administered through oral, intramuscular, intranasal, subcutaneous, and intradermal routes to treat cancer, infectious diseases, and other diseases including zoonotic diseases.

Vaccine Adjuvants Market Segmentation

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Vaccine Adjuvants Market Size and growth rate 2025 to 2029: Graph

Vaccine Adjuvants Market Size 2025 And Growth Rate

The vaccine adjuvants market size has grown strongly in recent years. It will grow from$1.89 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing vaccine development, prevalence of infectious diseases, government initiatives and immunization programs, research and development investments, globalization of vaccine distribution

Vaccine Adjuvants Market Growth Forecast

The vaccine adjuvants market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine portfolio, global immunization goals, collaborations and partnerships, focus on therapeutic vaccines. Major trends in the forecast period include advancements in adjuvant technologies, focus on immunogenicity enhancement, combination adjuvants for enhanced effectiveness, demand for safer and well-tolerated adjuvants, personalized vaccines and adjuvants.

Book your 30 minutes free consultation with our research experts

Vaccine Adjuvants Market Driver: Rising Infectious Disease Prevalence Fuels Growth In The Vaccine Adjuvants Market

The rising prevalence of infectious diseases is expected to propel the growth of the vaccine adjuvants market going forward. Infectious diseases refer to infections caused by viruses, bacteria, fungi, or parasites. Vaccines are used to treat these infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For instance, according to the 2022 World Health Organization (WHO) report, an estimated 10.6 million people are infected with tuberculosis globally in 2021, 1.6 million died, and 1.5 million people acquired HIV in 2021 while 650,000 people lost their lives due to it. Therefore, the rising prevalence of infectious diseases will drive the vaccine adjuvants market.

Vaccine Adjuvants Market Driver: Elevated Funding For Vaccine Research Initiatives Catalyst For Growth In The Vaccine Adjuvants Market

The growing funding for vaccine research activities is expected to propel the growth of the vaccine adjuvants market going forward. Vaccine research activities can be defined as comprehensive scientific endeavors aimed at developing, testing, and improving vaccines to prevent infectious diseases. Research activities play a vital role in developing, testing, and optimizing potential adjuvant candidates from various sources, including natural products, synthetic compounds, and even bacteria or viruses. For instance, in October 2023, the United States Department of Health and Human Services, a US-based provider of essential human services, announced Project NextGen with a $500 Million investment to begin developing Phase 2b clinical trial plans and technologies that develop cutting-edge next-generation vaccination and treatment platforms. Therefore, the growing funding for vaccine research activities is driving the growth of the vaccine adjuvants market.

Global Vaccine Adjuvants Market Major Players

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Global Vaccine Adjuvants Market Trend: Sustainable Innovations Driving Growth In The Vaccine Adjuvants Market

Product innovations are a key trend gaining popularity in the vaccine adjuvants market. Companies operating in the vaccine adjuvants market are focusing on adopting innovative solutions to strengthen their market position in the market. For instance, in December 2022, Evonik Industries, a Germany-based chemical manufacturing company, introduced PhytoSquene, a plant-based squalene derived from amaranth oil. This sustainable alternative to traditional shark-derived squalene is designed for use in vaccine adjuvants and other pharmaceutical applications, enhancing vaccine efficacy by boosting immune responses. The development of PhytoSquene underscores the growing emphasis on sustainability in the pharmaceutical sector.

Global Vaccine Adjuvants Market Trend: Innovation In The Vaccine Adjuvants Market With A Plant-Based Squalene For Enhanced Vaccine Efficacy

Major companies operating in the vaccine adjuvants market are focused on developing innovative products, such as plant-based squalene, to gain a competitive edge in the market. Plant-based squalene is a sustainable and cruelty-free alternative to the traditional squalene derived from shark liver oil. For instance, in December 2022, Evonik Industries AG, a Germany-based specialty chemicals company, launched PhytoSquene, a plant-based squalene for use in adjuvants to boost vaccine efficacy. It is used in adjuvants for parenteral vaccines, with potential for expansion into other pharmaceutical and cosmetic applications. The oil used to make PhytoSquene comes from the herbaceous plant known as amaranth (Amaranthus caudatus), which is grown all over the world. Its botanical origin guarantees purity, quality, and consistency from batch to batch. For patients who are unable to utilize products derived from animals due to cultural or religious beliefs, PhytoSquene offers an additional solution.

Vaccine Adjuvants Market Merger And Acquisition: Gsk Enhances Portfolio With Acquisition Of Affinivax Inc. In Vaccine Adjuvants Market

In August 2022, GSK PLC, a UK-based pharmaceutical and biotechnology company, acquired Affinivax Inc. for a deal amount of $3.3 billion. The acquisition of Affinivax strengthens GSK's strategy to build a substantial portfolio of specialized novel drugs and vaccines. It comprises a next-generation 24-valent pneumococcal vaccine adjuvant (AFX3772), which is based on the incredibly ground-breaking Multiple Antigen Presenting System (MAPSTM) platform technology and is currently in phase II development. Affinivax Inc. is a UK-based clinical-stage biopharmaceutical company operating in the vaccine adjuvant market.

Regional Analysis For The Global Vaccine Adjuvants Market

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vaccine adjuvants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vaccine Adjuvants Market?

The vaccine adjuvants market consists of sales of adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and saponin-based adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Vaccine Adjuvants Industry?

The vaccine adjuvants market research report is one of a series of new reports from The Business Research Company that provides vaccine adjuvants market statistics, including the vaccine adjuvants industry's global market size, regional shares, competitors with a vaccine adjuvants market share, detailed vaccine adjuvants market segments, market trends, and opportunities, and any further data you may need to thrive in the vaccine adjuvants industry. This vaccine adjuvants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vaccine Adjuvants Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.03 billion
Revenue Forecast In 2034	$2.89 billion
Growth Rate	CAGR of 9.2% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types 2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants 3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal 4) By Disease: Cancer, Infectious Diseases, Other Diseases Subsegments: 1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions 2) By Pathogen Components: Bacterial Components, Viral Components 3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles 4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems 5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Vaccine Adjuvants Market Characteristics

3. Vaccine Adjuvants Market Trends And Strategies

4. Vaccine Adjuvants Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Vaccine Adjuvants Growth Analysis And Strategic Analysis Framework

5.1. Global Vaccine Adjuvants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Vaccine Adjuvants Market Growth Rate Analysis

5.4. Global Vaccine Adjuvants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Vaccine Adjuvants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Vaccine Adjuvants Total Addressable Market (TAM)

6. Vaccine Adjuvants Market Segmentation

6.1. Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adjuvant Emulsions

Pathogen Components

Particulate Adjuvants

Combination Adjuvants

Other Product Types

6.2. Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Vaccine Adjuvants

Veterinary Vaccine Adjuvants

6.3. Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intramuscular

Intranasal

Subcutaneous

Intradermal

6.4. Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Infectious Diseases

Other Diseases

6.5. Global Vaccine Adjuvants Market, Sub-Segmentation Of Adjuvant Emulsions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oil-In-Water Emulsions

Water-In-Oil Emulsions

6.6. Global Vaccine Adjuvants Market, Sub-Segmentation Of Pathogen Components, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bacterial Components

Viral Components

6.7. Global Vaccine Adjuvants Market, Sub-Segmentation Of Particulate Adjuvants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Liposomes

Nanoparticles

Microparticles

6.8. Global Vaccine Adjuvants Market, Sub-Segmentation Of Combination Adjuvants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mixed Emulsions

Multiple Component Systems

6.9. Global Vaccine Adjuvants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Synthetic Adjuvants

Natural Adjuvants

7. Vaccine Adjuvants Market Regional And Country Analysis

7.1. Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vaccine Adjuvants Market

8.1. Asia-Pacific Vaccine Adjuvants Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vaccine Adjuvants Market

9.1. China Vaccine Adjuvants Market Overview

9.2. China Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vaccine Adjuvants Market

10.1. India Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vaccine Adjuvants Market

11.1. Japan Vaccine Adjuvants Market Overview

11.2. Japan Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vaccine Adjuvants Market

12.1. Australia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vaccine Adjuvants Market

13.1. Indonesia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vaccine Adjuvants Market

14.1. South Korea Vaccine Adjuvants Market Overview

14.2. South Korea Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vaccine Adjuvants Market

15.1. Western Europe Vaccine Adjuvants Market Overview

15.2. Western Europe Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vaccine Adjuvants Market

16.1. UK Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vaccine Adjuvants Market

17.1. Germany Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vaccine Adjuvants Market

18.1. France Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vaccine Adjuvants Market

19.1. Italy Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vaccine Adjuvants Market

20.1. Spain Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vaccine Adjuvants Market

21.1. Eastern Europe Vaccine Adjuvants Market Overview

21.2. Eastern Europe Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vaccine Adjuvants Market

22.1. Russia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vaccine Adjuvants Market

23.1. North America Vaccine Adjuvants Market Overview

23.2. North America Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vaccine Adjuvants Market

24.1. USA Vaccine Adjuvants Market Overview

24.2. USA Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vaccine Adjuvants Market

25.1. Canada Vaccine Adjuvants Market Overview

25.2. Canada Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vaccine Adjuvants Market

26.1. South America Vaccine Adjuvants Market Overview

26.2. South America Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vaccine Adjuvants Market

27.1. Brazil Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vaccine Adjuvants Market

28.1. Middle East Vaccine Adjuvants Market Overview

28.2. Middle East Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vaccine Adjuvants Market

29.1. Africa Vaccine Adjuvants Market Overview

29.2. Africa Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vaccine Adjuvants Market Competitive Landscape And Company Profiles

30.1. Vaccine Adjuvants Market Competitive Landscape

30.2. Vaccine Adjuvants Market Company Profiles

30.2.1. GlaxoSmithKline Plc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novavax Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. SPI Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Agenus Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

31. Vaccine Adjuvants Market Other Major And Innovative Companies

31.1. InvivoGen Limited

31.2. Brenntag Biosector A/S

31.3. Adjuvatis

31.4. Merck KGaA

31.5. Croda International Plc

31.6. Seppic Inc

31.7. OZ Biosciences

31.8. Avanti Polar Lipids Inc

31.9. Astellas Pharma Inc

31.10. Virometix AG

31.11. MPV Technologies Limited

31.12. Adjuvance Technologies Inc.

31.13. Novartis AG

31.14. Vaxine Pty Ltd

31.15. SBI Biotech Co. Ltd.

32. Global Vaccine Adjuvants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vaccine Adjuvants Market

34. Recent Developments In The Vaccine Adjuvants Market

35. Vaccine Adjuvants Market High Potential Countries, Segments and Strategies

35.1 Vaccine Adjuvants Market In 2029 - Countries Offering Most New Opportunities

35.2 Vaccine Adjuvants Market In 2029 - Segments Offering Most New Opportunities

35.3 Vaccine Adjuvants Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Vaccine Adjuvants Market, Sub-Segmentation Of Adjuvant Emulsions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Vaccine Adjuvants Market, Sub-Segmentation Of Pathogen Components, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Vaccine Adjuvants Market, Sub-Segmentation Of Particulate Adjuvants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Vaccine Adjuvants Market, Sub-Segmentation Of Combination Adjuvants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Vaccine Adjuvants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: GlaxoSmithKline Plc. Financial Performance

Table 81: Novavax Inc. Financial Performance

Table 82: SPI Pharma Inc. Financial Performance

Table 83: Agenus Inc. Financial Performance

Table 84: CSL Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Vaccine Adjuvants Market, Sub-Segmentation Of Adjuvant Emulsions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Vaccine Adjuvants Market, Sub-Segmentation Of Pathogen Components, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Vaccine Adjuvants Market, Sub-Segmentation Of Particulate Adjuvants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Vaccine Adjuvants Market, Sub-Segmentation Of Combination Adjuvants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Vaccine Adjuvants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: GlaxoSmithKline Plc. Financial Performance

Figure 81: Novavax Inc. Financial Performance

Figure 82: SPI Pharma Inc. Financial Performance

Figure 83: Agenus Inc. Financial Performance

Figure 84: CSL Limited Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the alpha mannosidosis research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Ethylene Global Market Report 2023 – By Feedstock (Naphtha, Ethane, Propane, Butane, Other Feedstocks), By Application (Polyethylene, Ethylene oxide, Ethylene benzene, Ethylene dichloride, Vinyl Acetate, Alpha Olefins), By End User Industry (Packaging, Automotive, Construction, Agrochemical, Textile) – Market Size, Trends, And Global Forecast 2023-2032

View Report

Genetically Modified Crops Global Market Report 2025 – By Trait (Herbicide Tolerance (HT), Insect Resistance (IR), Stacked Traits (ST), Other Traits), By Crop (Soybean, Cotton, Maize, Oilseed Rape, Other Crops), By Technique (Gene Guns, Electroporation, Microinjection, Agrobacterium, Other Techniques), By Type of Modification (Transgenic, Cis-genic, Sub-genic, Multiple Trait Integration, By Application (Scientific Research, Agriculture Crops) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Agricultural Implement Global Market Report 2025 – By Type (Farm Machinery And Equipment, Lawn And Garden Tractor And Home Lawn And Garden Equipment), By Operation (Autonomous, Semi-autonomous, Manual), By Capacity (Small, Medium, Large), By Application (Land Development and Seed Bed Preparation, Sowing and Planting, Weed Management, Plant Protection, Harvesting and Threshing, Post-Harvest and Agro Processing) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Ethylene-Petrochemicals Global Market Report 2025 – By Feedstock (Naphtha, Ethane, Propane, Butane, Other Feedstocks), By Application (Polyethylene, Ethylene oxide, Ethylene benzene, Ethylene dichloride, Vinyl Acetate, Alpha Olefins), By End User Industry (Packaging, Automotive, Construction, Agrochemical, Textile) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Emulsifiers Global Market Report 2025 – By Product (Lecithin, Mono And Di-Glycerides, Stearyl Lactylates, Sorbitan Esters, Polyglycerol Esters, Other Products), By Chemical Structure (Natural, Synthetics, Semi-Synthetics), By Application (Food Emulsifiers, Cosmetics And Personal Care, Oilfield Chemicals, Pharmaceutical, Agrochemicals, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

AgroScience Global Market Report 2025 – By Product (Biopesticides, Biostimulants, GM Seeds), By Active Ingredient (Acid-based biostimulants, Extract-based biostimulants), By Application (Crops, Food & Vegetable) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chitosan Global Market Report 2025 – By Grade (Pharmaceutical Grade, Industrial Grade, Food Grade), By Source (Shrimp, Squid, Crab, Krill, Other Sources), By Application (Water Treatment, Food and Beverages, Cosmetics, Medical and Pharmaceuticals, Agrochemicals, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chemicals Global Market Report 2025 – By Type (General Chemical Product, Printing Inks, Toiletries, Soap and Cleaning Compounds, Adhesives, Paints and Coatings, Pesticide and Other Agricultural Chemicals, Chemical Fertilizers, Synthetic Rubber and Fibers, Plastic Material and Resins, Ethyl Alcohol and Other Basic Organic Chemical, Other Basic Inorganic Chemical, Synthetic Dye and Pigment, Industrial Gas, Petrochemicals), By Type of Intermediate Chemicals (Methanol, Ethylene Oxide, Propylene Oxide), By End User (Pharmaceuticals, Agrochemicals, Water Treatment, Construction, Paints and Dyes, Oil & Gas, Rubber Chemicals, Surfactants, Personal Care, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Vaccine Adjuvants market?

How will the Vaccine Adjuvants market drivers and restraints affect the market dynamics? What forces will shape the Vaccine Adjuvants industry going forward?

The Vaccine Adjuvants market major growth driver - Rising Infectious Disease Prevalence Fuels Growth In The Vaccine Adjuvants Market. For further insights on the Vaccine Adjuvants market, request a sample here

What is the forecast market size or the forecast market value of the Vaccine Adjuvants market?

The Vaccine Adjuvants market size has grown strongly in recent years. The vaccine adjuvants market size has grown strongly in recent years. It will grow from$1.89 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing vaccine development, prevalence of infectious diseases, government initiatives and immunization programs, research and development investments, globalization of vaccine distribution The vaccine adjuvants market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine portfolio, global immunization goals, collaborations and partnerships, focus on therapeutic vaccines. Major trends in the forecast period include advancements in adjuvant technologies, focus on immunogenicity enhancement, combination adjuvants for enhanced effectiveness, demand for safer and well-tolerated adjuvants, personalized vaccines and adjuvants. For further insights on the Vaccine Adjuvants market, request a sample here

How is the Vaccine Adjuvants market segmented?

The vaccine adjuvants market covered in this report is segmented –
1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases Subsegments:
1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions
2) By Pathogen Components: Bacterial Components, Viral Components
3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles
4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems
5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants For further insights on the Vaccine Adjuvants market, request a sample here

Which region has the largest share of the Vaccine Adjuvants market? What are the other regions covered in the report?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Vaccine Adjuvants market, request a sample here.

Who are the major players in the Vaccine Adjuvants market?

What are the key trends in the Vaccine Adjuvants market?

Major trends in the Vaccine Adjuvants market include Sustainable Innovations Driving Growth In The Vaccine Adjuvants Market. For further insights on the Vaccine Adjuvants market, request a sample here.

What are the major opportunities in the Vaccine Adjuvants market? What are the strategies for the Vaccine Adjuvants market?

For detailed insights on the major opportunities and strategies in the Vaccine Adjuvants market, request a sample here.

How does the Vaccine Adjuvants market relate to the overall economy and other similar markets?

For detailed insights on Vaccine Adjuvants's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Vaccine Adjuvants industry?

For detailed insights on the mergers and acquisitions in the Vaccine Adjuvants industry, request a sample here.

What are the key dynamics influencing the Vaccine Adjuvants market growth? SWOT analysis of the Vaccine Adjuvants market.

For detailed insights on the key dynamics influencing the Vaccine Adjuvants market growth and SWOT analysis of the Vaccine Adjuvants industry, request a sample here.